Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT00181051
Other study ID # PEA
Secondary ID CSET 2002/948
Status Suspended
Phase Phase 3
First received September 13, 2005
Last updated September 13, 2005
Start date February 2003

Study information

Verified date September 2005
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study type Interventional

Clinical Trial Summary

Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Potentials monitoring to standrad practice in order to assess if AEP monitoring can improve recovery delay (main criteria) or intraoperative hemodynamic stability (secondary criteria). Patients were randomized in 2 groups, stratified by center. Group I : AEP guided anesthesia, Group II: Blind AEP record, standard practice.


Recruitment information / eligibility

Status Suspended
Enrollment 128
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- ASA status I-II patients

- aged 18 - 65 years

- scheduled for general surgery (except laparoscopic interventions) lasting longer than 1 hour.

Exclusion Criteria:

- Body weight < 70% or > 150% ideal body weight

- neurological disorder and hearing disorders (being not able to communicate with the patient in a normal tone)

- use of any medication interfering with pharmacological effect of the study including alcohol misuse or drugs.

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Alaris AEP monitor


Locations

Country Name City State
France Institut Gustave-Roussy Villejuif

Sponsors (1)

Lead Sponsor Collaborator
Gustave Roussy, Cancer Campus, Grand Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Influence of AEP guided anesthesia on recovery delay